Jci_page_head_homepage_01 Jci_page_head_homepage_02
Wei Du, F. Susan Wong, Ming O. Li, Jian Peng, Hao Qi, Richard A. Flavell, Robert Sherwin, Li Wen
Published in Volume 116, Issue 5
J Clin Invest. 2006; 116(5):1360–1370 doi:10.1172/JCI27030
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0627030
Figure 6
Adoptive transfer of diabetogenic or protective cells deficient in TGF-β receptor.

(A) Splenocytes from diabetic TGF-βDNRII NOD (open circles) or diabetic TGF-βDNRII BDC2.5 NOD (open triangles) mice were transferred into NOD.scid recipients (107 per recipient) alone (n = 5 for each group) or together with an equal number of 2H6 NOD splenocytes (filled circles and filled triangles, n = 5 for each group). All the mice were monitored for glycosuria weekly, and the experiments were terminated when the mice developed diabetes. (B) Diabetic spleen cells from either NOD (open circles) or BDC2.5 NOD (open triangles) mice were transferred into NOD.scid recipients (107 per recipient) alone (n = 4 for each group) or together with an equal number of TGF-βDNRII–deficient 2H6 NOD cells (2H6 DNRII, filled circles and filled triangles, n = 5 for each group). All the mice were monitored for glycosuria weekly and the experiments were terminated when the mice developed diabetes.